How does SARS-CoV-2 cause lymphopenia when T cells barely express ACE-2 receptors?

In the bid to lock up patent rights to a grow­ing suite of gene edit­ing tech­nolo­gies, Ar­bor Biotech­nolo­gies has ac­quired a small start­up found­ed by

One of the back­bones of can­cer med­i­cine is shut­ting down key can­cer-dri­ving path­ways to kill tu­mor cells. But for years, re­searchers have no­ticed hy­per­ac­ti­va­tion of